SCIENTIFIC HUB

Follow the evidence.

20.444 articles found

Source record

A human developmental and adult brain atlas benchmarks dopaminergic stem cell models and cell therapy candidates

Bocchi VD, To K, Weber L, Zumbo P, Kim L, Shida IY, Yang D, Storm P, Fiorenzano A, Sozzi E, Hackland J, Xu C, Kim TW, Memi F, Drummond NJ, Bestard-Cuche N, Corsinotti A, Bayraktar OA, Sawarkar N, Tipon RS, Sudhakar KK, Zhong A, Koo SY, Piao J, He X, Horsfall D, Basurto-Lozada D, Zhou T, Tabar V, Powell JE, Barker RA, Treutlein B, Croft G, Morizane A, Kunath T, Parmar M, Blaess S, Awatramani R, Betel D, Teichmann SA, Studer L.

· 2026-06-22

DOI: 10.64898/2026.06.19.733041

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Expression of Concern: Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.

The Editors Of The Lancet.

Lancet · 2026-06-22

DOI: 10.1016/s0140-6736(26)01241-9PMID: 42330995

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.